CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2020.

Excerpt from:
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh